Heart Failure with Preserved Ejection Fraction — A Metabolic Disease?
Yigal M. Pinto
Abstract
Yigal Pinto comments on the findings of the STEP-HFpEF trial, which measured the effects of treatment with semaglutide in patients with heart failure with preserved ejection fraction and obesity.
Topics & Concepts
MedicineEjection fractionHeart failure with preserved ejection fractionHeart failureCardiologyInternal medicineSemaglutideObesityDiabetes mellitusType 2 diabetesEndocrinologyLiraglutideCardiovascular Function and Risk FactorsHeart Failure Treatment and ManagementDiabetes Treatment and Management